HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Ylikoski, A. Articles by Nurmi, M. Search for Related Content PubMed PubMed Citation Articles by Ylikoski, A. Articles by Nurmi, M. Related Collections Proteomics and Protein Markers Cancer Diagnostics (since 2002)

Simultaneous Quantification of Prostate-specific Antigen and Human Glandular Kallikrein 2 mRNA in Blood Samples from Patients with Prostate Cancer and Benign Disease

¹ Department of Biotechnology, University of Turku, 20520 Turku, Finland.
Departments of
² Clinical Chemistry and
⁴ Urology, Turku University Hospital, 20520 Turku, Finland.

³ Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, University Hospital, 20502 Malmö, Sweden.

^aAddress correspondence to this author at: Department of Biotechnology, University of Turku, Tykistökatu 6 A 6th Floor, 20520 Turku, Finland. Fax 358-2-3338050; e-mail Timo.Lovgren{at}utu.fi.

Background: Detection or quantification of circulating cancer cells has been proposed as an aid in detection and monitoring of several solid tumors. We investigated the classification accuracy of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) mRNA copy numbers in blood for the differentiation of patients with prostate cancer (PC) and benign disease.

Methods: PSA and hK2 mRNA expression was studied in blood samples from 51 men with PC and 19 men with benign disease. Among the PC patients, 10 had organ-confined disease (pT1–pT2). We used a multiplexed reverse transcription-PCR assay with two highly target-like mRNA internal standards for the simultaneous quantification of PSA and hK2 mRNA. An external calibration curve covered the range of 10²–10⁶ mRNA copies.

Results: PSA and hK2 mRNA were detected in 41 of 51 (median, 1200 copies/0.5 mL of blood) and 43 of 51 (median, 3800 copies/0.5 mL of blood) patients with PC, respectively, whereas only 1 of 19 men with benign disease was positive for both mRNAs (1500 PSA and 3100 hK2 mRNA copies/0.5 mL of blood; P <0.0001, Mann–Whitney U-test). Of the 10 patients with organ-confined PC, only 3 with low Gleason scores (5) were negative for both PSA and hK2 (P = 0.02, Mann–Whitney U-test).

Conclusions: The presence of PC cells in the blood circulation is an early event in PC progression, and quantitative assays for PSA and hK2 mRNA discriminate benign from PC cases. Further studies are needed to determine the diagnostic accuracy and prognostic value of the assays.

The following articles in journals at HighWire Press have cited this article:

				C. Alix-Panabieres, X. Rebillard, J.-P. Brouillet, E. Barbotte, F. Iborra, B. Segui, T. Maudelonde, C. Jolivet-Reynaud, and J.-P. Vendrell Detection of Circulating Prostate-Specific Antigen-Secreting Cells in Prostate Cancer Patients Clin. Chem., August 1, 2005; 51(8): 1538 - 1541. [Full Text] [PDF]

				J. P. Dutcher The Prognostic Role of Detection of Circulating Melanoma Cells in the Blood J. Clin. Oncol., March 1, 2003; 21(5): 757 - 759. [Full Text] [PDF]